Rachel McMinn, Founder & CEO

About Neurogene

At Neurogene, our focus is to develop life-changing genetic medicines for patients and their families affected by rare, devastating neurological diseases.

OUR VISION

Push the boundaries of genetic medicine to address complex and devastating neurological diseases.

OUR MISSION

Turn devastating neurological diseases into treatable conditions, to improve the lives of patients and families impacted by these rare diseases.

OUR CULTURE

Build a corporate culture that nurtures innovation, creative problem solving, and a strong sense of purpose, while honoring the patient/caregiver mindset.

Our Core Values

IT’S BETTER TOGETHER

We address the incredible complexity of gene therapy as a team, gathering insights, ideas, and perspectives from our internal and external subject matter experts and stakeholders.

KEEP AN OPEN MIND

In the rapidly evolving field of gene therapy, we regularly ask ourselves what we can do differently to solve emerging challenges.

PATIENTS AND FAMILIES ARE WAITING

Knowing that families urgently await treatment options, we work with a sense of urgency balanced with the necessary scientific rigor to advance our gene therapy programs.

REIMAGINE THE FUTURE

We prize innovation, encourage new ideas, and actualize our vision to drive transformation in genetic medicine.

Our Leadership Team

Neurogene’s senior leadership team brings a strong sense of purpose and extensive drug development experience to the task. Our founding leaders include:

Board of Directors